Nxera Pharma has announced that its subsidiary, Nxera Pharma Japan has entered into an exclusive license, supply and com...
Jyong Biotech, a Taiwan-based science-driven biotechnology company dedicated to the development and commercialisation of...
Merck, known as MSD outside of the United States and Canada, has inaugurated its state-of-the-art ADVANCE research facil...
AtomVie Global Radiopharma, a global contract developer and manufacturer (CDMO) for radiopharmaceuticals, has announced ...
Charles River Laboratories International, Inc. and Magellan Stem Cells, a private Australian biotech and cell-therapy fi...
Brii Biosciences, a China-based biotechnology company developing therapies to improve patient health and choice across d...
Japan-based JCR Pharmaceuticals Co., a global specialty biopharmaceutical company dedicated to developing therapies...
As laboratories across Asia-Pacific face growing demands for faster, more precise and reproducible analytical testing, F...
Swiss firm Alentis Therapeutics and South Korea based PinotBio have entered into a research collaboration and licensing ...
360biolabs, a BioAgilytix company, has opened a new laboratory in Sydney, bringing its established bioanalytical experti...
As pharmaceutical innovation accelerates, mature medicines remain essential to healthcare systems, y...
US-based Waters Corporation has launched Waters AI Link, a software capability that brings Anthropic's Model Context Pro...
Theramex, a London-headquartered specialty pharmaceutical company dedicated to women and their health, and China-based A...
Chinese startup Rona Therapeutics has granted Roche an exclusive worldwide license for Rona's investigational RNAi candi...
South Korea-based NTL HEALTHCARE, a women's health AI company, has announced the global launch of CerviCARE® AI AT, ...
Americhem, a global leader in custom polymer solutions, recently celebrated the opening of its new clean compounding fac...
ITOCHU Corporation has signed a capital alliance agreement with MOLCURE Inc., which possesses AI-driven drug discovery t...
Australia-based Firebrick Pharma has secured firm commitments from strategic investors for approximately $732k, through ...
Japan-based Ono Pharmaceutical has entered into an exclusive license agreement with Biohaven, together with its wholly o...
South Korea-based Lunit, a leading provider of AI for cancer diagnostics and precision oncology, has announced a strateg...
Taiwan-based Foresee Pharmaceuticals has been notified by its licensing partner, Changchun GeneScience Pharmaceutical (G...
Japan-based Shimadzu Corporation has started the development and validation of a mass spectrometry (MS) solution for cor...
US-based Danaher Corporation has announced plans to launch its first AI-powered autonomous lab, designed to help researc...
South Korea-based LOTTE Biologics, a contract development and manufacturing (CDMO) organisation, and Alvotech, a global ...
GE HealthCare has announced a definitive agreement to acquire SOFIE Biosciences, a leading US-based CMO for PET radiopha...
